Skip to main content
. 2014 Dec 16;13:123. doi: 10.1186/s40200-014-0123-0

Table 1.

Characteristics of TB patients in relation to HbA1c at baseline and at baseline- 3 months

Characteristics All hospitalized patients Patients with HbA1c level at baseline and at 3-months Patients with only baseline HbA1c level p-value
Number of patients 317 158 159
Age (Mean ± SD) yrs 55.33 ± 21.04 52.83 ± 21.24 57.82 ± 20.60 0.03
Male gender 163 (51.4%) 77 (48.73%) 86 (54.10%) 0.37
History of smoking 96 (30.3%) 44 (27.85%) 52 (32.70%) 0.40
History of opium use 74 (23.3%) 31 (19.62%) 43 (27%) 0.14
Positive HIV test 17 (5.4%) 5 (3.20%) 12 (7.50%) 0.13
Diabetes mellitus (known) 46 (14.5%) 22 (13.92%) 24 (15.10%) 0.87
Pulmonary tuberculosis 296 (93.4%) 151 (95.57%) 145 (91.20%) 0.20
Symptom duration (months) 3.89 ± 3.18 3.90 ± 3.37 3.88 ± 2.99 0.94
Smear grade of sputum
 3+ 114 (36%) 59 (37.34%) 55 (34.6%) 0.79
 2+ 32 (10.1%) 13 (8.23%) 19 (11.9%)
 1+ 77 (24.3%) 38 (24.05%) 39 (24.5%)
 Scanty 44 (13.9%) 24 (15.20%) 20 (12.6%)
 Negative 50 (15.8%) 24 (15.20%) 26 (16.4%)
HbA1c (baseline) 7.2 ± 2 7.2 ± 2 7.1 ± 2 0.37
FBG (baseline) 119.1 ± 51.1 119 ± 53 119.3 ± 49.3 0.94
Cavitary lesion 155 (48.9%) 75 (47.50%) 80 (50.3%) 0.65

Student’s t-test and x2 test or Fisher exact is used when appropriate.

Abbreviations: TB tuberculosis, HbA1c Glycosylated haemoglobin, SD Standard deviation, HIV human immunodeficiency virus, FBG Fasting blood glucose.